Register for email alerts and news feeds:
This journal | BMJ Group
rss
Published Online First: 15 March 2007. doi:10.1136/adc.2006.109389
Archives of Disease in Childhood 2007;92:409-411
Copyright © 2007 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health.

ORIGINAL ARTICLE

Variations in captopril formulations used to treat children with heart failure: a survey in the United kingdom

Hussain Mulla1, Magdi Tofeig2, Frances Bu’Lock2, Nilesh Samani3, Hitesh C Pandya2

1 Centre for Pharmacy Practice Research, Glenfield Hospital, Leicester, UK
2 Congenital and Paediatric Heart Service, Glenfield Hospital, Leicester, UK
3 British Heart Foundation, Department of Cardiovascular Sciences, University of Leicester, Glenfield General Hospital, Leicester, UK

Correspondence to:
Dr H C Pandya
Congenital and Paediatric Heart Service, Glenfield Hospital, Groby Road, Leicester LE3 9QP, UK;hp28{at}leicester.ac.uk

Background and objective: Different liquid formulations of a drug prepared for use in children cannot be assumed to have therapeutic equivalence. The objective of this study was to ascertain the interhospital constancy of unlicensed liquid captopril formulations used to treat children with heart failure in the UK.

Design: A questionnaire-based telephone survey.

Setting: 13 tertiary paediatric cardiac centres in the UK and 13 large hospitals referring patients to these centres.

Participants: The study included pharmacists responsible for providing the pharmaceutical input to children with congenital heart disease or a pharmacist designated to cover paediatric services. Technical staff employed by "specials" manufacturers also participated.

Results: Four hospitals dispensed captopril tablets for crushing and dissolving in water before administration; the remaining 22 used nine different liquid formulations of captopril. Only three cardiac centres and their referring hospitals were found to be using the same liquid captopril formulations; 10 centres and their referring hospitals were using completely different captopril formulations.

Conclusions: This survey shows that paediatric cardiac centres and their referring hospitals use a variety of unlicensed liquid captopril formulations interchangeably. This degree of inconsistency raises issues about optimal captopril dosing and potential toxicity, such that its use may influence paediatric cardiac surgical and interventional outcomes.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Article

A brief digest of the May issue
Arch. Dis. Child. 2007 92: e5. [Extract] [Full Text] [PDF]

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Latest from ADC

 

ADC is co-owned by the RCPCH and is the official journal of the European Academy of Paediatrics

BMJ Careers - Latest Paediatrics and Paediatric Surgery Jobs

Paediatrics and Paediatric Surgery Jobs